Gene expression and secretion of atrial natriuretic peptide by murine macrophages

A M Vollmar1, R Schulz

  • 1Institute of Pharmacology, Toxicology and Pharmacy, University of Munich, Germany.

Insights

Atrial natriuretic peptide (ANP) is produced by macrophages, key immune cells. Macrophage activation by substances like LPS increases ANP production, suggesting a role for ANP in host defense mechanisms.

Area of Science:

  • Immunology
  • Endocrinology
  • Molecular Biology

Background:

  • Atrial natriuretic peptide (ANP) expression is noted in activated macrophages within the involuted rat thymus.
  • Macrophages are crucial immune cells involved in host defense.

Purpose of the Study:

  • To investigate the presence and synthesis of ANP in different macrophage populations.
  • To determine the regulation of ANP expression and release by immune-stimulating agents.

Main Methods:

  • Competitive PCR was used to quantify ANP mRNA levels in peritoneal (PM) and bone marrow-derived macrophages (BMM).
  • Macrophage cultures were treated with lipopolysaccharide (LPS), zymosan, dexamethasone (Dex), and phorbol 12-myristate 13-acetate (PMA).
  • Intracellular and secreted levels of the active ANP fragment (ANP99-126) were measured.

Main Results:

  • ANP mRNA was detected in both PM and BMM, indicating ANP is a common macrophage constituent.
  • LPS and zymosan significantly increased ANP mRNA levels (up to sixfold).
  • Dexamethasone showed moderate effects, while PMA had no significant impact on ANP mRNA abundance. Both LPS and Dex increased intracellular and secreted ANP99-126.

Conclusions:

  • Macrophages synthesize and release biologically active ANP (ANP99-126).
  • ANP expression in macrophages is modulated by immune cell activators.
  • ANP may play a role in the intricate mechanisms of host defense executed by macrophages.

Related Concept Videos